Role of ANGPTL8 in NAFLD Improvement after Bariatric Surgery in Experimental and Human Obesity
Angiopoietin-like protein 8 (ANGPTL8) is an hepatokine altered in several metabolic conditions, such as obesity, type 2 diabetes, dyslipidemia and nonalcoholic fatty liver disease (NAFLD). We sought to explore whether ANGPTL8 is involved in NAFLD amelioration after bariatric surgery in experimental...
Main Authors: | Carolina M. Perdomo, Javier Gómez-Ambrosi, Sara Becerril, Víctor Valentí, Rafael Moncada, Eva M. Fernández-Sáez, Leire Méndez-Giménez, Silvia Ezquerro, Victoria Catalán, Camilo Silva, Javier Escalada, Gema Frühbeck, Amaia Rodríguez |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-11-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/23/12945 |
Similar Items
-
Effect of guanylin peptides on pancreas steatosis and function in experimental diet-induced obesity and after bariatric surgery
by: Aarón Otero, et al.
Published: (2023-05-01) -
Increased Aquaporin-7 Expression Is Associated with Changes in Rat Brown Adipose Tissue Whitening in Obesity: Impact of Cold Exposure and Bariatric Surgery
by: Gema Frühbeck, et al.
Published: (2023-02-01) -
Gut Microbiome and Metabolites in Patients with NAFLD and after Bariatric Surgery: A Comprehensive Review
by: Jacqueline Hoozemans, et al.
Published: (2021-05-01) -
ANGPTL8 requires ANGPTL3 to inhibit lipoprotein lipase and plasma triglyceride clearance[S]
by: Jorge F. Haller, et al.
Published: (2017-06-01) -
Role of the angiopoietin-like protein family in the progression of NAFLD
by: Xin Su, et al.
Published: (2024-04-01)